Blueprint Medicines Corp at JMP Securities Life Sciences Conference (Virtual) Transcript
Excellent. So good afternoon, everyone. It's my distinct pleasure to introduce Blueprint Medicines Corporation, commercial-stage company with some really important milestone drivers coming up later this year that can expand their opportunity significantly.
Joining us virtually is Christy Rossi, COO; and Percy Carter, CSO. As you guys know, the format that I like is to kind of start off with a little bit of an overview for those of you in the audience who might not know Blueprint. If you can maybe spend two to five minutes there, Christy, just introducing the company before we jump into some specific questions.
So happy to. First, I wanted to thank you, Ren, for having us and the whole JMP team, and also for your flexibility today. We had intended to be there in person. We have to do a little bit of a switch to virtual. I think we're probably not the only people who are impacted by some of the weather issues in New York this morning. So thank you for
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |